一个可激活的聚合物纳米间,用于逆转糖尿病骨质疏松症的进展
Shenhua Li1, Zhibo He1, Ran Zhu2
1Department of Trauma Orthopaedics, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200092, China.
Biomaterials
|August 17, 2025
概括
研究人员开发了一种智能纳米药物,通过释放近红外染料和药物来检测和治疗糖尿病骨质疏松症 (DOP),以响应疾病特异信号,为诊断和治疗提供双重方法.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病骨质疏松症 (DOP) 是糖尿病的严重并发症,导致骨质损失和骨折风险增加.
- 早期发现和有效治疗DOP仍然是重大的临床挑战.
研究的目的:
- 开发一种智能聚合物纳米药物 (RAFP NP),用于同时诊断和治疗糖尿病骨质疏松症.
- 设计能够响应DOP早期环境刺激的纳米探针,用于向药物输送和成像.
主要方法:
- 一种两性共聚物 (PLGA-TK-cRGD) 自组装成RAFPNP,封装一个近红外染料 (Cy5) 和一种抗ferroptosis药物 (Fer-1).
- 利用整合素向 (αvβ3受体) 和反应性氧物种 (ROS) 响应性用于向药物释放和成像.
- 评估RAFP NP在准DOP,诱导光和释放Fer-1以抑制骨质细胞铁亡的性能.
主要成果:
- 通过整合蛋白αvβ3受体相互作用,RAFP NP有效地准DOP区域.
- 在DOP环境中ROS水平升高会触发硫基甲 (TK) 裂变,导致NP分解.
- 释放的Cy5使DOP的NIR光成像成为可能,而Fer-1抑制骨质细胞铁亡并促进骨质生成.
结论:
- RAFP NPs为糖尿病骨质疏松症的早期检测和治疗提供了一个有希望的策略.
- 开发的纳米探针展示了在复杂疾病环境中智能,响应性药物输送和成像的潜力.
- 这种方法解决了针对糖尿病骨质疏松症进展的有效干预措施的未满足的临床需求.
相关概念视频
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
01:31Diabetic Foot Ulcer
33
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory...
33
01:27Diabetic Retinopathy
55
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
01:28Diabetic Nephropathy
32
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32
01:22Diabetic Neuropathy
59
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59